About integra lifesciences holdings corp. - IART
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
IART At a Glance
Integra LifeSciences Holdings Corp.
1100 Campus Road
Princeton, New Jersey 08540
| Phone | 1-609-275-0500 | Revenue | 1.64B | |
| Industry | Medical Specialties | Net Income | -516,474,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 1.535% | |
| Fiscal Year-end | 12 / 2026 | Employees | 4,427 | |
| View SEC Filings |
IART Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.582 |
| Price to Book Ratio | 0.927 |
| Price to Cash Flow Ratio | 18.90 |
| Enterprise Value to EBITDA | 8.147 |
| Enterprise Value to Sales | 1.664 |
| Total Debt to Enterprise Value | 0.747 |
IART Efficiency
| Revenue/Employee | 369,379.941 |
| Income Per Employee | -116,664.558 |
| Receivables Turnover | 5.724 |
| Total Asset Turnover | 0.428 |
IART Liquidity
| Current Ratio | 2.543 |
| Quick Ratio | 1.462 |
| Cash Ratio | 0.578 |
IART Profitability
| Gross Margin | 52.705 |
| Operating Margin | 11.146 |
| Pretax Margin | -34.46 |
| Net Margin | -31.584 |
| Return on Assets | -13.521 |
| Return on Equity | -39.902 |
| Return on Total Capital | -16.787 |
| Return on Invested Capital | -17.674 |
IART Capital Structure
| Total Debt to Total Equity | 194.85 |
| Total Debt to Total Capital | 66.084 |
| Total Debt to Total Assets | 56.446 |
| Long-Term Debt to Equity | 181.378 |
| Long-Term Debt to Total Capital | 61.516 |